Risk of illness, hospitalization and death in a cohort of blood donors in Italy

References

• Casale G, Bignamini M, de Nicola P. Does blood donation prolong life expectancy? Vox Sang 1983;45:398-9
   PubMed Web of Science ®Google Scholar
• Merk K, Mattsson B, Mattsson A, et al. The incidence of cancer among blood donors. Int J Epidemiol 1990;19:505-9
   PubMed Web of Science ®Google Scholar
• Tuomainen TP, Salonen R, Nyyssonen K, et al. Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland. BMJ 1997;314:793-4
   PubMed Web of Science ®Google Scholar
• Meyers DG, Strickland D, Maloley PA, et al. Possible association of a reduction in cardiovascular events with blood donation. Heart 1997;78:188-93
   PubMed Web of Science ®Google Scholar
• Salonen TJ, Tuomainen TP, Salonen R, et al. Donation of blood is associated with reduced risk of myocardial infarction The Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Epidemiol 1998;148:445-51
   PubMed Web of Science ®Google Scholar
• Meyers DG, Jensen KC, Menitove JE. A historical cohort study of the effect of lowering body iron through blood donation on incident cardiac events. Transfusion 2002;42:1135-9
   PubMed Web of Science ®Google Scholar
• Zuck TF, Thomson RA, Schreiber GB, et al. The Retrovirus Epidemiology Donor Study (REDS): rationale and methods. Transfusion 1995;35:944-51
   PubMed Web of Science ®Google Scholar
• Glynn SA, Kleinman SH, Schreiber GB, et al. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS). JAMA 2000;284:229-35
   PubMed Web of Science ®Google Scholar
• Newman BH. Donor reactions and injuries from whole blood donation. Transfus Med Rev 1997;11:64-75
   PubMed Web of Science ®Google Scholar
• Edgren G, Tran TN, Hjalgrim H, et al. Improving health profile of blood donors as a consequence of transfusion safety efforts. Transfusion 2007;47:2017-24
   PubMed Web of Science ®Google Scholar
• Albanes D, Winick M. Are cell number and cell proliferation risk factors for cancer? J Natl Cancer Inst 1988;80:772-4
   PubMed Web of Science ®Google Scholar
• Cohen SM, Ellwein LB. Cell proliferation in carcinogenesis. Science 1990;249:1007-11
   PubMed Web of Science ®Google Scholar
• Ieromnimon V, Kruger J, Schmidt R, et al. Effect of blood donations on the profile of lymphocytic cells. Vox Sang 1981;41:165-71
   PubMed Web of Science ®Google Scholar
• Lasek W, Jakobisiak M, Plodziszewska M, et al. The influence of blood donation on antibody-dependent cellular cytotoxicity (ADCC) in voluntary blood bank donors. Arch Immunol Ther Exp (Warsz) 1988;36:37-43
   PubMed Web of Science ®Google Scholar
• Lasek W, Jakobisiak M, Grochowska M, et al. Two patterns of NK activity changes following blood donation: decrease in the beginners and restoration in regular blood bank donors. Arch Immunol Ther Exp (Warsz) 1992;40:191-44
   PubMedGoogle Scholar
• Lasek W, Jakobisiak M, Stoklosa T. Decreased natural killer cell activity in whole-blood donors does not seem to result in increased cancer incidence. Transfusion 1994;34:359-60
   PubMed Web of Science ®Google Scholar
• Edgren G, Reilly M, Hjalgrim H, et al. Donation frequency, iron loss, and risk of cancer among blood donors. J Natl Cancer Inst 2008;100:572-9
   PubMed Web of Science ®Google Scholar
• Atsma F, Veldhuizen I, Verbeek A, et al. Healthy donor effect: its magnitude in health research among blood donors. Transfusion 2011;51:1820-8
   PubMed Web of Science ®Google Scholar
• Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined co-morbidity index. J Clin Epidemiol 1994;47:1245-51
   PubMed Web of Science ®Google Scholar
• Schneeweiss S, Maclure M. Use of co-morbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol 2000;29:891-8
   PubMed Web of Science ®Google Scholar
• Gillespie TW, Hillyer CD. Blood donors and factors impacting the blood donation decision. Transfus Med Rev 2002;16:115-30
   PubMed Web of Science ®Google Scholar
• Ascherio A, Rimm EB, Giovannucci E, et al. Blood donations and risk of coronary heart disease in men. Circulation 2001;03:52-7
   Google Scholar
• Selby JV, Friedman GD. Epidemiologic evidence of an association between body iron stores and risk of cancer. Int J Cancer 1988;41:677-82
   PubMed Web of Science ®Google Scholar
• Knekt P, Reunanen A, Takkunen H, et al. Body iron stores and risk of cancer. Int J Cancer 1994;56:379-82
   PubMed Web of Science ®Google Scholar
• de Valk B, Marx JJ. Iron, atherosclerosis, and ischemic heart disease. Arch Intern Med 1999;159:1542-8
   PubMed Web of Science ®Google Scholar
• Haidari M, Javadi E, Sanati A, et al. Association of increased ferritin with premature coronary stenosis in men. Clin Chem 2001;47:1666-72
   PubMed Web of Science ®Google Scholar
• Zacharski LR, Chow BK, Howes PS, et al. Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial. JAMA 2007;297:603-10
   PubMed Web of Science ®Google Scholar
• Sempos CT, Looker AC, Gillum RF, et al. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994;330:1119-24
   PubMed Web of Science ®Google Scholar
• Knuiman MW, Divitini ML, Olynyk JK, et al. Serum ferritin and cardiovascular disease: a 17-year follow-up study in Busselton, Western Australia. Am J Epidemiol 2003;158:144-9
   PubMed Web of Science ®Google Scholar
• Nelson RL, Davis FG, Sutter E, et al. Body iron stores and risk of colonic neoplasia. J Natl Cancer Inst 1994;86:455-60
   PubMed Web of Science ®Google Scholar
• Nelson RL. Iron and colorectal cancer risk: human studies. Nutr Rev 2001;59:140-8
   PubMed Web of Science ®Google Scholar
• Stevens RG, Jones DY, Micozzi MS, et al. Body iron stores and the risk of cancer. N Engl J Med 1988;319:1047-52
   PubMed Web of Science ®Google Scholar
• Barradas MA, Jeremy JY, Kontoghiorghes GJ, et al. Iron chelators inhibit human platelet aggregation, thromboxane A2 synthesis and lipoxygenase activity. FEBS Lett 1989;245:105-9
   PubMed Web of Science ®Google Scholar
• Logroscino G, Chen H, Wing A, Ascherio A. Blood donations, iron stores, and risk of Parkinson’s disease. Mov Disord 2006;21:835-8
   PubMed Web of Science ®Google Scholar
• Burch JW, Mair DC, Meny GM, et al. The risk of posterior subcapsular cataracts in granulocyte donors. Transfusion 2005;45:1701-8
   PubMed Web of Science ®Google Scholar
• Jiang R, Ma J, Ascherio A, et al. Dietary iron intake and blood donations in relation to risk of type 2 diabetes in men: a prospective cohort study. Am J Clin Nutr 2004;79:70-5
   PubMed Web of Science ®Google Scholar
• Livesey JA, Manning RA, Meek JH, et al. Low serum iron levels are associated with elevated plasma levels of coagulation factor VIII and pulmonary emboli/deep venous thromboses in replicate cohorts of patients with hereditary haemorrhagic telangiectasia. Thorax 2012;67:328-33
   PubMed Web of Science ®Google Scholar
• Karger R, Weber C, Schmidt J, et al. Characterization of immune system alterations following preoperative autologous blood donation for elective hip replacement surgery. Transfus Med 2007;17:45-53
   PubMed Web of Science ®Google Scholar
• Tran-Mi B, Storch H, Seidel K, et al. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers. Vox Sang 2004;86:189-97
   PubMed Web of Science ®Google Scholar
• Ameratunga SN, Norton RN, Whitlock G, et al. The New Zealand Blood Donors’ Health Study: baseline findings of a large prospective cohort study of injury. Inj Prev 2002;8:66-9
   PubMed Web of Science ®Google Scholar
• Atsma F, de Vegt F. The healthy donor effect: a matter of selection bias and confounding. Transfusion 2011;51:1883-5
   PubMed Web of Science ®Google Scholar